NCGC00015208-06

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 10 USDMF, 10 CEP/COS, 11 JDMF, 1 EU WC, 7 KDMF, 18 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

FINISHED DOSAGE FORMULATIONS

543 FDF Dossiers, 126 FDA Orange Book, 160 Europe, 38 Canada, 129 South Africa, 90 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 100MG;1MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;RECTAL - 100MG;2MG, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 2 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 1 ICE Pharma, 16 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 13 Kirsch Pharma, 4 ACG Worldwide, 21 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 46 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 4 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 3 Finar, 15 Gangwal Chemicals, 1 Hayashibara, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 26 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 46 Roquette, 20 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 62 Thickeners and Stabilizers, 59 Coating Systems & Additives, 56 Solubilizers, 56 Topical, 49 Direct Compression, 49 Disintegrants & Superdisintegrants, 46 Parenteral, 44 Taste Masking, 42 Granulation, 33 Controlled & Modified Release, 30 Film Formers & Plasticizers, 26 Emulsifying Agents, 26 Chewable & Orodispersible Aids, 26 Lubricants & Glidants, 20 Surfactant & Foaming Agents, 18 Co-Processed Excipients, 12 API Stability Enhancers, 10 Rheology Modifiers, 9 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

34 News #PharmaBuzz

34 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

91 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 15 Others

ANALYTICAL

1 BioAnalytical Methods, 13 Analytical Methods

$ Xls

Filters

NCGC00015208-06

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

ASPEN

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

ASPEN

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for NCGC00015208-06? Find Coloring Agents used in NCGC00015208-06 to address drug delivery challenges on PharmaCompass.

NCGC00015208-06

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

66 API Suppliers

10 USDMF

10 CEP/COS

11 JDMF

1 EU WC

7 KDMF

18 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

47 Drugs in Development

FINISHED DOSAGE FORMULATIONS

543 FDF Dossiers

126 FDA Orange Book

160 Europe

38 Canada

129 South Africa

90 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 100MG;1MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;RECTAL - 100MG;2MG

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

13 Rochem International Inc

31 SPI Pharma

2 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

1 ICE Pharma

16 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

13 Kirsch Pharma

4 ACG Worldwide

21 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

46 BASF

1 Bioplus Life Sciences

3 CD Formulation

4 Clariant

13 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

3 Finar

15 Gangwal Chemicals

1 Hayashibara

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

26 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

11 Pluviaendo

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 325MG;50MG;40MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons